Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)

NCT06131385 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-11-28

No results posted yet for this study

Summary

This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.

Conditions

  • Stroke, Acute

Interventions

DRUG

intravenous thrombolysis

Intravenous thrombolysis using thrombolytic drugs such as ateplase and teneplase.

Sponsors & Collaborators

  • Zhengzhou Yuan

    lead OTHER

Principal Investigators

  • Zhengzhou Yuan · Department of Neurology, Affiliated Hospital of Southwest Medical University, Lu

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2045-12-15
Completion
2046-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06131385 on ClinicalTrials.gov